Back
Aligos Therapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
45
ALGS
Aligos Therapeutics
Last Price:
$6.18
Seasonality Move:
-16.73%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
The current trend is relatively stagnant and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.6 | Buy |
| 20-day SMA: | 5.47 | Buy |
| 50-day SMA: | 5.93 | Buy |
| 200-day SMA: | 15.92 | Sell |
| 8-day EMA: | 5.61 | Buy |
| 20-day EMA: | 5.62 | Buy |
| 50-day EMA: | 7.45 | Sell |
| 200-day EMA: | 14.46 | Sell |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 51.67 | Buy |
| Chaikin Money Flow: | 126712 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.01 - 5.95) | Buy |
| Bollinger Bands (100): | (4.02 - 23.62) | Sell |
Aligos Therapeutics Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 5.95 while ALGS 8-day simple moving average is 5.60, which is a Buy signal.
-
The stock price of ALGS is 5.95 while Aligos Therapeutics 20-day SMA is 5.47, which makes it a Buy.
-
Aligos Therapeutics 50-day simple moving average is 5.93 while ALGS share price is 5.95, making it a Buy technically.
-
ALGS stock price is 5.95 and Aligos Therapeutics 200-day simple moving average is 15.92, creating a Sell signal.
ALGS Technical Analysis vs Fundamental Analysis
Sell
45
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a SellThe current Aligos Therapeutics [ALGS] share price is $5.95. The Score for ALGS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
36.4M
Price in USD:
5.95
Share Volume:
126.7K
Aligos Therapeutics 52-Week Range
52-Week High:
46.80
52-Week Low:
3.76
Sell
45
Aligos Therapeutics (ALGS)
is a Sell
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?The Aligos Therapeutics stock price is 5.95 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is overvalued.
Is Aligos Therapeutics Stock a Buy?
-
Aligos Therapeutics share price is 5.95 while ALGS 8-day exponential moving average is 5.61, which is a Buy signal.
-
The stock price of ALGS is 5.95 while Aligos Therapeutics 20-day EMA is 5.62, which makes it a Buy.
-
Aligos Therapeutics 50-day exponential moving average is 7.45 while ALGS share price is 5.95, making it a Sell technically.
-
ALGS stock price is 5.95 and Aligos Therapeutics 200-day simple moving average is 14.46, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Aligos Therapeutics is a Sell
-
Aligos Therapeutics Relative Strength Index (RSI) is 51.67, which suggest Aligos Therapeutics is overbought
-
The Bollinger Bands (25) for Aligos Therapeutics is (5.01 - 5.95), which suggest Aligos Therapeutics is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics is (4.02 - 23.62), which suggest Aligos Therapeutics is a Sell
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.